
Omnes Capital's investments


GEEV
Thanks to a simple and fun service, "Geevers" can easily give and receive items for free in the proximity of their own homes. Available in Paris, Lyon, Marseille, Lille, Bordeaux, Nantes and Toulouse, GEEV has become an obvious alternative to selling, unnecessary storage and the proliferation of waste in the public space.

Antabio
Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. Two of Antabio’s programs have received Wellcome Trust Seeding Drug Discovery Awards to date: [i] a novel, safe and efficacious inhibitor of bacterial metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections and [ii] a first-in-class inhibitor of Pseudomonas virulence to be co-administered with standard-of-care antibiotics for the long-term management of chronic respiratory infections. This second program has recently received up to $8.9 million funding from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).

Marquetis
Headquartered in Boulogne Billancourt and part of the French marketing and communications sector since 1996, Marquetis has been managed for more than 20 years by Virginie Massa. Marquetis operates through its subsidiaries Marquetis One, Marquetis Connect and Marquetis Call. It offers a 360 ° service, ranging from global communication consulting to automated cross-channel marketing in SaaS mode.

Ilmatar Energy

Tiller

Groupe Mistral

Nanomakers

Tilkee
Tilkee was founded by Sylvain Tillon and Timothée Saumet in decembre 2013. The company offers a complete suite of document tracking solutions: Tilkee for Sales, Tilkee for Marketing, Tilkee for Jobs and Tilkee for Events. Tilkee currently employs 24 people and is growing in Europe (Germany, United Kingdom, Spain). Tilkee’s clients include EDF, Orange, Schneider Electric, Credit Agricole and Adecco

Circet
Founded in 1993, Circet is the market leader, having pursued an active acquisition policy for eight years.